Literature DB >> 21798459

XDR tuberculosis.

Jakko van Ingen, Wiel Cm de Lange, Martin J Boeree, Michael D Iseman, Charles L Daley, Leonid B Heifets, Erik C Böttger, Dick van Soolingen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798459     DOI: 10.1016/S1473-3099(11)70200-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  1 in total

1.  The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks.

Authors:  Frederick A Sirgel; Robin M Warren; Erik C Böttger; Marisa Klopper; Thomas C Victor; Paul D van Helden
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.